$0.740
-0.018 (-2.49%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BRNS por análisis de gráficos similares
Alphio's BRNS stock price prediction model matches the current Barinthus Biotherapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.77 (+3.41%). The 1-week path is $0.78 (+5.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Barinthus Biotherapeutics PLC?
Barinthus Biotherapeutics PLC is a good buy right now due to its recent positive price momentum, with a 5-day change of +6.18% and a projected final change of +90.79% based on historical patterns. The RSI of 58.83 indicates that the stock is neither overbought nor oversold, suggesting potential for further gains. However, the main risk is the company's net income, which has been negative, with a recent EPS of -0.26, indicating ongoing profitability challenges.
BRNS cerró en $0.74 el Tuesday, tras bajar -2.49%
Barinthus Biotherapeutics PLC (BRNS) last closed at $0.7401, losing -2.49%. These facts feed the 1-day and 1-week BRNS price prediction above.
Factores de la previsión
Los factores de la previsión de Barinthus Biotherapeutics PLC (BRNS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BRNS, ordenadas por similitud.
Análisis de estacionalidad de BRNS
Historically the probability of a positive November return for BRNS is 0.00%. October offers the highest probability of a positive month at 50.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BRNS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.25 | $1.39 | $1.66 | +88.00% |
| Dec 2026 | $1.59 | $1.81 | $2.00 | +144.34% |
En 2026, se proyecta que Barinthus Biotherapeutics PLC (BRNS) oscile entre $1.25 y $2.00.
Previsión mensual de Barinthus Biotherapeutics PLC para 2026
En Nov de 2026, se proyecta que Barinthus Biotherapeutics PLC promedie $1.39, con un mínimo de $1.25 y un máximo de $1.66.
En Dec de 2026, se proyecta que Barinthus Biotherapeutics PLC promedie $1.81, con un mínimo de $1.59 y un máximo de $2.00.
Artículos relacionados
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.